Adverum Biotechnologies Inc (NASDAQ:ADVM) Shorts Increased By 18.96%

April 17, 2018 - By Sheila Anderson

Adverum Biotechnologies Inc (NASDAQ:ADVM) had an increase of its shares shorted by 18.96%. FINRA issued in April ADVM’s total 2.22 million shares shorted. The 1.87 million previous shares are up with 18.96%. Previous ADVM’s position will need 2 days to recover. It has 936,000 average volume. Float short on Adverum Biotechnologies Inc is 9.11%.

Its shares touched $6.35 on during the last trading session after 1.55% change.Currently Adverum Biotechnologies, Inc. is uptrending after 103.64% change in last April 17, 2017. ADVM has also 265,688 shares volume. The stock outperformed the S&P500 by 92.09%.

Adverum Biotechnologies, Inc., a gene therapy company, discovers and develops novel medicines for patients suffering from rare diseases or diseases of eye.The firm is valued at $394.80 million. The firm has a pipeline that includes product candidates to treat wet age-related macular degeneration , alpha 1 antitrypsin deficiency (A1AT), and hereditary angioedema.Last it reported negative earnings. The Company’s lead gene therapy programs include ADVM-022 and ADVM-032, which are in the preclinical development of new anti-VEGF gene therapy candidates for wAMD diseases; and ADVM-043, which is in patient enrollment in a phase 1/2 trial for the treatment of A1AT.

Adverum Biotechnologies, Inc. (NASDAQ:ADVM) Analyst Ratings Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.